{"id":"https://openalex.org/W4391507913","doi":"https://doi.org/10.1016/j.canlet.2024.216681","title":"Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC","display_name":"Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC","publication_year":2024,"publication_date":"2024-02-02","ids":{"openalex":"https://openalex.org/W4391507913","doi":"https://doi.org/10.1016/j.canlet.2024.216681","pmid":"https://pubmed.ncbi.nlm.nih.gov/38311054","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11622984"},"language":"en","primary_location":{"id":"doi:10.1016/j.canlet.2024.216681","doi":"https://doi.org/10.1016/j.canlet.2024.216681","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.canlet.2024.216681","pdf_url":null,"source":{"id":"https://openalex.org/S106234763","display_name":"Cancer Letters","issn_l":"0304-3835","issn":["0304-3835","1872-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.canlet.2024.216681","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024034968","display_name":"Kennady K. Bullock","orcid":"https://orcid.org/0000-0002-9773-3512","observed_orcids":["https://orcid.org/0000-0002-9773-3512"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kennady K. Bullock","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA"],"raw_orcid":"https://orcid.org/0000-0002-9773-3512","affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001839705","display_name":"Rebecca L. Shattuck-Brandt","orcid":"https://orcid.org/0000-0003-2163-3221","observed_orcids":["https://orcid.org/0000-0003-2163-3221"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Shattuck-Brandt","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA"],"raw_orcid":"https://orcid.org/0000-0003-2163-3221","affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061705746","display_name":"Carly Bess Scalise","orcid":"https://orcid.org/0000-0002-7612-7791","observed_orcids":["https://orcid.org/0000-0002-7612-7791"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carly Scalise","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101539438","display_name":"Weifeng Luo","orcid":"https://orcid.org/0000-0002-8042-7260","observed_orcids":["https://orcid.org/0000-0002-8042-7260"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weifeng Luo","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059563188","display_name":"Sheau\u2010Chiann Chen","orcid":"https://orcid.org/0000-0002-5574-1434","observed_orcids":["https://orcid.org/0000-0002-5574-1434"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheau-Chiann Chen","raw_affiliation_strings":["Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nabil Saleh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nabil Saleh","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030367169","display_name":"Paula I. Gonz\u00e1lez Ericsson","orcid":"https://orcid.org/0000-0002-6292-6963","observed_orcids":["https://orcid.org/0000-0002-6292-6963"]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula I. Gonzalez-Ericsson","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088254403","display_name":"Guadalupe Garcia","orcid":"https://orcid.org/0000-0002-8673-2303","observed_orcids":["https://orcid.org/0000-0002-8673-2303"]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guadalupe Garcia","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017831693","display_name":"Melinda E. Sanders","orcid":"https://orcid.org/0000-0001-7227-1764","observed_orcids":["https://orcid.org/0000-0001-7227-1764"]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda E. Sanders","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013233073","display_name":"Gregory Dan Ayers","orcid":"https://orcid.org/0000-0002-0892-350X","observed_orcids":["https://orcid.org/0000-0002-0892-350X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory D. Ayers","raw_affiliation_strings":["Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007111794","display_name":"Chi Wing Yan","orcid":"https://orcid.org/0000-0002-8658-7302","observed_orcids":["https://orcid.org/0000-0002-8658-7302"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chi Yan","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA. Electronic address: chi.yan@vanderbilt.edu","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA"],"raw_orcid":"https://orcid.org/0000-0002-8658-7302","affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA. Electronic address: chi.yan@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010542605","display_name":"Ann J. Richmond","orcid":"https://orcid.org/0000-0002-9580-900X","observed_orcids":["https://orcid.org/0000-0002-9580-900X"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210101790","display_name":"VA Tennessee Valley Healthcare System","ror":"https://ror.org/01c9rqr26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101790","https://openalex.org/I4210112672"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ann Richmond","raw_affiliation_strings":["Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: ann.richmond@vanderbilt.edu","Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":"https://orcid.org/0000-0002-9580-900X","affiliations":[{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA; Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: ann.richmond@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Department of Pharmacology, Vanderbilt School of Medicine, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Tennessee Valley Healthcare System, Department of Veteran Affairs, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210101790"]},{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5007111794","https://openalex.org/A5010542605"],"corresponding_institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4210101790","https://openalex.org/I4390039299","https://openalex.org/I901861585"],"apc_list":{"value":4260,"currency":"USD","value_usd":4260},"apc_paid":{"value":4260,"currency":"USD","value_usd":4260},"fwci":1.151,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.74888714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"586","issue":null,"first_page":"216681","last_page":"216681"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/akt-inhibition","display_name":"AKT inhibition","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9620000123977661},{"id":"https://openalex.org/keywords/phospho-akt","display_name":"phospho-Akt","score":0.9300000071525574},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/tumor-response-prediction","display_name":"tumor response prediction","score":0.6679999828338623},{"id":"https://openalex.org/keywords/pi3k-pathway-mutations","display_name":"PI3K pathway mutations","score":0.6970000267028809},{"id":"https://openalex.org/keywords/tumor-mutational-status","display_name":"tumor mutational status","score":0.5640000104904175},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.3619999885559082},{"id":"https://openalex.org/keywords/mouse-tumor-model","display_name":"mouse tumor model","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8622889518737793},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.8581252098083496},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6382297277450562},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5904072523117065},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4425746202468872},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.43829280138015747},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43205708265304565},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.36616402864456177},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3577447831630707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3014501929283142},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2928772568702698},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20672070980072021},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1725936233997345}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.canlet.2024.216681","doi":"https://doi.org/10.1016/j.canlet.2024.216681","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.canlet.2024.216681","pdf_url":null,"source":{"id":"https://openalex.org/S106234763","display_name":"Cancer Letters","issn_l":"0304-3835","issn":["0304-3835","1872-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Letters","raw_type":"journal-article"},{"id":"pmid:38311054","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38311054","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer letters","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11622984","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11622984","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11622984/pdf/nihms-2021796.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Lett","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.canlet.2024.216681","doi":"https://doi.org/10.1016/j.canlet.2024.216681","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.canlet.2024.216681","pdf_url":null,"source":{"id":"https://openalex.org/S106234763","display_name":"Cancer Letters","issn_l":"0304-3835","issn":["0304-3835","1872-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Letters","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1243813451","display_name":null,"funder_award_id":"CA 34590","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1300984159","display_name":null,"funder_award_id":"P30 CA 68485","funder_id":"https://openalex.org/F4320309601","funder_display_name":"Vanderbilt-Ingram Cancer Center"},{"id":"https://openalex.org/G1388609297","display_name":null,"funder_award_id":"S10OD023475","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2268269956","display_name":null,"funder_award_id":"DK-058404","funder_id":"https://openalex.org/F4320334532","funder_display_name":"Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center"},{"id":"https://openalex.org/G268010445","display_name":"Leica Bond RX","funder_award_id":"1s10od023475-01a1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G283432789","display_name":null,"funder_award_id":"I01BX002301","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G2867786555","display_name":"Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway","funder_award_id":"R01CA243326","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3152736877","display_name":null,"funder_award_id":"S10 OD023475-01A1","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3261201894","display_name":null,"funder_award_id":"101BX002301","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G3269002440","display_name":null,"funder_award_id":"P30 CA068485","funder_id":"https://openalex.org/F4320309601","funder_display_name":"Vanderbilt-Ingram Cancer Center"},{"id":"https://openalex.org/G3433274139","display_name":null,"funder_award_id":"P30 CA68485","funder_id":"https://openalex.org/F4320309151","funder_display_name":"Vanderbilt University"},{"id":"https://openalex.org/G3526814","display_name":null,"funder_award_id":"T32 CA009592","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G359867969","display_name":null,"funder_award_id":"IK6 BX005225","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G5220722603","display_name":"Enhancing triple negative breast cancer response to immune checkpoint inhibitor therapy via targeted therapies","funder_award_id":"F31CA271790","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5853943267","display_name":null,"funder_award_id":"CA68485","funder_id":"https://openalex.org/F4320309151","funder_display_name":"Vanderbilt University"},{"id":"https://openalex.org/G6188970379","display_name":"Chemokine Signals in the Premetastatic Niche Inhibit Metastasis","funder_award_id":"R01CA034590","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7520984233","display_name":null,"funder_award_id":"P30 CA68485","funder_id":"https://openalex.org/F4320334532","funder_display_name":"Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center"},{"id":"https://openalex.org/G7709962112","display_name":null,"funder_award_id":"S10 OD023475-01A1","funder_id":"https://openalex.org/F4320334532","funder_display_name":"Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center"},{"id":"https://openalex.org/G813343541","display_name":null,"funder_award_id":"5F31CA271790","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G9000312249","display_name":null,"funder_award_id":"CA34590","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000861568","display_name":"Microenvironmental Influences in Cancer","funder_award_id":"T32CA009592","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000862353","display_name":"Molecular and Cellular Basis for Digestive Diseases","funder_award_id":"P30DK058404","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G9000880732","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA068485","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320309151","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34"},{"id":"https://openalex.org/F4320309601","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/05dq2gs74"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334532","display_name":"Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center","ror":null},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391507913.pdf","grobid_xml":"https://content.openalex.org/works/W4391507913.grobid-xml"},"referenced_works_count":75,"referenced_works":["https://openalex.org/W1588880778","https://openalex.org/W1600186066","https://openalex.org/W1647534619","https://openalex.org/W1998203489","https://openalex.org/W2016804396","https://openalex.org/W2024556512","https://openalex.org/W2034471770","https://openalex.org/W2078131718","https://openalex.org/W2084875329","https://openalex.org/W2097773105","https://openalex.org/W2106036365","https://openalex.org/W2114843025","https://openalex.org/W2117497402","https://openalex.org/W2120498539","https://openalex.org/W2135131549","https://openalex.org/W2142153200","https://openalex.org/W2149441684","https://openalex.org/W2162147795","https://openalex.org/W2162409477","https://openalex.org/W2166875189","https://openalex.org/W2168284316","https://openalex.org/W2170637386","https://openalex.org/W2392652440","https://openalex.org/W2430731787","https://openalex.org/W2509236360","https://openalex.org/W2550697711","https://openalex.org/W2564136012","https://openalex.org/W2582393724","https://openalex.org/W2588923250","https://openalex.org/W2590028062","https://openalex.org/W2592628645","https://openalex.org/W2606692456","https://openalex.org/W2744377419","https://openalex.org/W2748521059","https://openalex.org/W2781227791","https://openalex.org/W2798022026","https://openalex.org/W2800799386","https://openalex.org/W2891700678","https://openalex.org/W2894776217","https://openalex.org/W2895515586","https://openalex.org/W2896209350","https://openalex.org/W2897827524","https://openalex.org/W2900046418","https://openalex.org/W2914345456","https://openalex.org/W2945644530","https://openalex.org/W2947372527","https://openalex.org/W2971220345","https://openalex.org/W2996625978","https://openalex.org/W3005834099","https://openalex.org/W3006140059","https://openalex.org/W3006930853","https://openalex.org/W3014067703","https://openalex.org/W3025589456","https://openalex.org/W3035075519","https://openalex.org/W3047645321","https://openalex.org/W3089446304","https://openalex.org/W3097171810","https://openalex.org/W3102028751","https://openalex.org/W3109853980","https://openalex.org/W3132667233","https://openalex.org/W3133519066","https://openalex.org/W3135946003","https://openalex.org/W3159932768","https://openalex.org/W3162666542","https://openalex.org/W3165585845","https://openalex.org/W3174345125","https://openalex.org/W3178993660","https://openalex.org/W3208558332","https://openalex.org/W3211064809","https://openalex.org/W3215622661","https://openalex.org/W3215701750","https://openalex.org/W4200296405","https://openalex.org/W4210957314","https://openalex.org/W4225122437","https://openalex.org/W4283790062"],"related_works":["https://openalex.org/W4283790062","https://openalex.org/W2943363006","https://openalex.org/W2403972047","https://openalex.org/W4416185364","https://openalex.org/W4399533339","https://openalex.org/W2786784128","https://openalex.org/W2134134362","https://openalex.org/W4282936570","https://openalex.org/W3083348216","https://openalex.org/W2036980023"],"abstract_inverted_index":{"Triple-negative":[0],"breast":[1,9,41],"cancer":[2,10],"(TNBC)":[3],"is":[4,37,58],"a":[5,31],"heterogeneous":[6],"and":[7,26,53,115,149,210],"challenging-to-treat":[8],"subtype.":[11],"The":[12,34],"clinical":[13],"introduction":[14],"of":[15,47,64,98,125,133,165,205],"immune":[16,52],"checkpoint":[17],"inhibitors":[18,63],"(ICI)":[19],"for":[20],"TNBC":[21,89,220],"has":[22],"had":[23],"mixed":[24],"results,":[25],"very":[27],"few":[28],"patients":[29],"achieved":[30],"durable":[32],"response.":[33],"PI3K/AKT":[35],"pathway":[36,50,66,138,167],"frequently":[38],"mutated":[39],"in":[40,51,61,87,105,150,156,184,217,227],"cancer.":[42],"Given":[43],"the":[44,48,69,83,126,163,180,207],"important":[45],"roles":[46],"PI3K":[49,127,137,166],"tumor":[54,119],"cell":[55,113],"signaling,":[56],"there":[57],"an":[59,185],"interest":[60],"using":[62],"this":[65],"to":[67,71,76,85,94,102,145,170,182,193,197,224],"increase":[68],"response":[70,84,99,144,164,181],"ICI.":[72,108,153,230],"This":[73],"study":[74],"sought":[75,93],"determine":[77],"if":[78],"AKT":[79,103,146,171,177,190,225],"inhibition":[80,104,147,178,191,226],"could":[81,161],"enhance":[82],"ICI":[86,183],"murine":[88,111],"models.":[90],"We":[91],"further":[92],"understand":[95],"underlying":[96],"mechanisms":[97],"or":[100],"non-response":[101],"combination":[106,151,228],"with":[107,143,152,229],"Using":[109],"four":[110],"TNBC-like":[112],"lines":[114],"corresponding":[116],"orthotopic":[117],"mouse":[118],"models,":[120],"we":[121,174],"found":[122],"that":[123,176,203],"hyperactivity":[124],"pathway,":[128],"as":[129],"evidenced":[130],"by":[131],"levels":[132,213],"phospho-AKT":[134,211],"rather":[135],"than":[136],"mutational":[139,208],"status,":[140],"was":[141],"associated":[142],"alone":[148],"Additional":[154],"mutations":[155],"other":[157],"growth":[158],"regulatory":[159],"pathways":[160],"override":[162],"mutant":[168],"tumors":[169,221],"inhibition.":[172],"Furthermore,":[173],"observed":[175],"enhanced":[179],"already":[186],"sensitive":[187],"model.":[188],"However,":[189],"failed":[192],"convert":[194],"ICI-resistant":[195],"tumors,":[196],"responsive":[198],"tumors.":[199],"These":[200],"findings":[201],"suggest":[202],"analysis":[204],"both":[206],"status":[209],"protein":[212],"may":[214],"be":[215],"beneficial":[216],"predicting":[218],"which":[219],"will":[222],"respond":[223]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-02-04T00:00:00"}